The effect of extracorporeal photopheresis on T cell response in chronic graft-versus-host disease

References

• Burt RK, Loh Y, Pearce W, et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008;299:925–936.
   PubMed Web of Science ®Google Scholar
• Couriel DR, Hosing C, Saliba R, et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006;107:3074–3080.
   PubMed Web of Science ®Google Scholar
• Kaloyannidis P, Mallouri D. The role of the extracorporeal photopheresis in the management of the graft-versus-host disease. Transfus Apher Sci 2012;46:211–219.
   PubMed Web of Science ®Google Scholar
• Kanold J, Messina C, Halle P, et al. Update on extracorporeal photochemotherapy for graft-versus-host disease treatment. Bone Marrow Transplant 2005;35(Suppl. 1):S69–71.
   PubMed Web of Science ®Google Scholar
• Alcindor T, Gorgun G, Miller KB, et al. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood 2001;98:1622–1625.
   PubMed Web of Science ®Google Scholar
• Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 2002;100:941–947.
   PubMed Web of Science ®Google Scholar
• Biagi E, Di Biaso I, Leoni V, et al. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4 + CD25+ GITR+ Foxp3 + CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007;84:31–39.
   PubMed Web of Science ®Google Scholar
• Schmitt S, Johnson TS, Karakhanova S, et al. Extracorporeal photophoresis augments function of CD4 + CD25+ FoxP3 + regulatory T cells by triggering adenosine production. Transplantation 2009; 88:411–416.
   PubMed Web of Science ®Google Scholar
• Martin PJ, Weisdorf D, Przepiorka D, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 2006;12:491–505.
   PubMed Web of Science ®Google Scholar
• Paczesny S, Krijanovski OI, Braun TM, et al. A biomarker panel for acute graft-versus-host disease. Blood 2009;113:273–278.
   PubMed Web of Science ®Google Scholar
• Flowers ME, Inamoto Y, Carpenter PA, et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011;117:3214–3219.
   PubMed Web of Science ®Google Scholar
• Ball LM, Egeler RM, Party EPW. Acute GvHD: pathogenesis and classification. Bone Marrow Transplant 2008;41(Suppl. 2):S58–64.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Flowers ME. Recognizing and managing chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program 2008:134–141.
   Google Scholar
• Williamson E, Garside P, Bradley JA, et al. IL-12 is a central mediator of acute graft-versus-host disease in mice. J Immunol 1996;157:689–699.
   PubMed Web of Science ®Google Scholar
• Ferrara JL, Cooke KR, Pan L, et al. The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 1996;14:473–489.
   PubMed Web of Science ®Google Scholar
• Tanaka J, Imamura M, Kasai M, et al. Th2 cytokines (IL-4, IL-10 and IL-13) and IL-12 mRNA expression by concanavalin A-stimulated peripheral blood mononuclear cells during chronic graft-versus-host disease. Eur J Haematol 1996;57:111–113.
   PubMed Web of Science ®Google Scholar
• Ratajczak P, Janin A, Peffault de Latour R, et al. Th17/Treg ratio in human graft-versus-host disease. Blood 2010;116:1165–1171.
   PubMed Web of Science ®Google Scholar
• Croudace JE, Inman CF, Abbotts BE, et al. Chemokine-mediated tissue recruitment of CXCR3 + CD4+ T cells plays a major role in the pathogenesis of chronic GVHD. Blood 2012;120:4246–4255.
   PubMed Web of Science ®Google Scholar
• Hayashida JN, Nakamura S, Toyoshima T, et al. Possible involvement of cytokines, chemokines and chemokine receptors in the initiation and progression of chronic GVHD. Bone Marrow Transplant 2013;48:115–123.
   PubMed Web of Science ®Google Scholar
• Reinhardt K, Foell D, Vogl T, et al. Monocyte-induced development of Th17 cells and the release of S100 proteins are involved in the pathogenesis of graft-versus-host disease. J Immunol 2014;193:3355–3365.
   PubMed Web of Science ®Google Scholar
• Chen X, Vodanovic-Jankovic S, Johnson B, et al. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007;110:3804–3813.
   PubMed Web of Science ®Google Scholar
• De Wit D, Van Mechelen M, Zanin C, et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol 1993; 150:361–366.
   PubMed Web of Science ®Google Scholar
• Allen RD, Staley TA, Sidman CL. Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur J Immunol 1993;23:333–337.
   PubMed Web of Science ®Google Scholar
• Szabo SJ, Kim ST, Costa GL, et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000;100:655–669.
   PubMed Web of Science ®Google Scholar
• Lugo-Villarino G, Maldonado-Lopez R, Possemato R, et al. T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc Natl Acad Sci U S A 2003;100:7749–7754.
   PubMed Web of Science ®Google Scholar
• McLane LM, Banerjee PP, Cosma GL, et al. Differential localization of T-bet and Eomes in CD8 T cell memory populations. J Immunol 2013;190:3207–3215.
   PubMed Web of Science ®Google Scholar
• Silva MG, Ferreira Neto L, Guimaraes A, et al. Long-term follow-up of lymphocyte populations and cellular cytokine production in patients with chronic graft-versus-host disease treated with extracorporeal photopheresis. Haematologica 2005;90:565–567.
   PubMed Web of Science ®Google Scholar
• Darvay A, Salooja N, Russell-Jones R. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease. J Eur Acad Dermatol Venereol 2004;18:279–284.
   PubMed Web of Science ®Google Scholar
• Di Renzo M, Sbano P, De Aloe G, et al. Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients. Clin Exp Immunol 2008;151:407–413.
   PubMed Web of Science ®Google Scholar
• Jonson CO, Pihl M, Nyholm C, et al. Regulatory T cell- associated activity in photopheresis-induced immune tolerance in recent onset type 1 diabetes children. Clin Exp Immunol 2008;153: 174–181.
   PubMed Web of Science ®Google Scholar
• Lamioni A, Carsetti R, Legato A, et al. Induction of regulatory T cells after prophylactic treatment with photopheresis in renal transplant recipients. Transplantation 2007;83:1393–1396.
   PubMed Web of Science ®Google Scholar
• Di Biaso I, Di Maio L, Bugarin C, et al. Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. Transplantation 2009;87:1422–1425.
   PubMed Web of Science ®Google Scholar